137 related articles for article (PubMed ID: 6003869)
1. [Use of the hemagglutination test for detecting Vi-antibodies in the sera of patients with typhoid fever and chronic carrier state during treatment with levomycetin].
Anan'ina NA
Zh Mikrobiol Epidemiol Immunobiol; 1966 Oct; 43(10):146. PubMed ID: 6003869
[No Abstract] [Full Text] [Related]
2. [The content of Vi-antibodies and 7S Vi-antibodies in the serum of typhoid patients treated with Vi-antigen and levomycetin].
Sukhoroslova LI; Andreeva NP
Zh Mikrobiol Epidemiol Immunobiol; 1968 May; 45(5):83-7. PubMed ID: 5733721
[No Abstract] [Full Text] [Related]
3. [Changes in serum bactericidal properties in patients with typhoid fever and chronic carrier state treated with levomycetin].
Anan'ina NA
Zh Mikrobiol Epidemiol Immunobiol; 1966 Oct; 43(10):98-101. PubMed ID: 4976155
[No Abstract] [Full Text] [Related]
4. [VI-antibody formation in typhoid patients treated with VI-antigen, pentoxyl and levomycetin].
Kuliev MM
Zh Mikrobiol Epidemiol Immunobiol; 1968 Dec; 45(12):55-9. PubMed ID: 5733863
[No Abstract] [Full Text] [Related]
5. Vi serology in screening of typhoid carriers: improved specificity by detection of Vi antibodies by counterimmunoelectrophoresis.
Chau PY; Tsang RS
J Hyg (Lond); 1982 Oct; 89(2):261-7. PubMed ID: 7130702
[TBL] [Abstract][Full Text] [Related]
6. [Immunologic shifts in typhoid patients following immuno-antibiotic therapy with levomycetin and VI-antigen according to the results of the passive VI-hemagglutination test].
Shneĭder VP
Zh Mikrobiol Epidemiol Immunobiol; 1966 Jun; 43(6):26-32. PubMed ID: 6004905
[No Abstract] [Full Text] [Related]
7. [Bacteriological and serological investigations on guinea pigs, experimentally infected with S. typhi (bacterial excretors)].
Wolff I; Henneberg G
Zentralbl Bakteriol Orig; 1969 Jan; 209(2):186-95. PubMed ID: 5386531
[No Abstract] [Full Text] [Related]
8. [A study of the avidity of Vi antibodies in typhoid fever patients and chronic carriers].
Bunin KV; Firsanov VI; Kravtsov EG; Sukhoroslova LI; Kapuka LP
Zh Mikrobiol Epidemiol Immunobiol; 1976 Oct; (10):65-9. PubMed ID: 1007716
[TBL] [Abstract][Full Text] [Related]
9. [Clinical evaluation of the passive hemagglutination test in typhoid fever].
Kossakiewicz-Sulkońska B
Przegl Epidemiol; 1970; 24(4):483-9. PubMed ID: 5495312
[No Abstract] [Full Text] [Related]
10. [Prevention of bacterial carrier state in typhoid and paratyphoid patients by means of antibiotic-vaccineotherapy. II. The dynamics of immunologic indices in typhoid and paratyphoid patients treated with levomycetin and dry alcoholic typho-paratyphoid B divaccine].
Tendetnik IuIa; Kilesso VA; Vydrina EI; Leĭtman MZ; Taratorina OM
Zh Mikrobiol Epidemiol Immunobiol; 1966 Apr; 43(4):73-80. PubMed ID: 4978572
[No Abstract] [Full Text] [Related]
11. [Chronic carrier state of Salmonella typhi and passive hemagglutination reaction after chloromycetin therapy].
Prokopowicz D; Lotocka K; Wyrzykowski J; Szymajda B; Kulikowska A
Przegl Lek; 1971; 27(3):265-7. PubMed ID: 5575025
[No Abstract] [Full Text] [Related]
12. [Clinical-epidemiological parallels in patients suffering from typhoid and paratyphoid fever treated with levomycetin in combination with vaccine].
Musabaev IK; Nevskiĭ MV; Ambartsumov SM; Mikhaĭlovskaia OG; Kotiuminskaia NA; David'ian AO
Sov Med; 1966 Jun; 29(6):64-9. PubMed ID: 4965445
[No Abstract] [Full Text] [Related]
13. [Recurrent typhoid in patients treated with levomycetin].
Shneĭder VP
Klin Med (Mosk); 1966 Dec; 44(12):124-8. PubMed ID: 6004337
[No Abstract] [Full Text] [Related]
14. Typhoid carriers. I. Immunoelectrophoretic study of antibodies in the sera of carriers and patients with typhoid fever.
Ciznár I; Odler I; Mikulková V
J Hyg Epidemiol Microbiol Immunol; 1967; 11(4):433-8. PubMed ID: 5629907
[No Abstract] [Full Text] [Related]
15. Typhoid fever.
Christie AB
Postgrad Med J; 1966 Jan; 42(483):41-3. PubMed ID: 5902897
[No Abstract] [Full Text] [Related]
16. [Serum H-antibody indices based on indirect hemagglutination reaction data in typhoid patients, convalescents and bacterial carriers].
Venknevich BK
Zh Mikrobiol Epidemiol Immunobiol; 1975 Sep; 0(9):133-4. PubMed ID: 1199579
[No Abstract] [Full Text] [Related]
17. [Anti-typhoid vaccine prophylaxis and vaccine therapy in carrier states and in typhoid fever. I. Convalescent carriers].
Buşilă VT; Vasilescu I; Vâlceanu M; Fitărău A; Pintea L
Microbiol Parazitol Epidemiol (Bucur); 1970; 15(4):305-11. PubMed ID: 5456200
[No Abstract] [Full Text] [Related]
18. [Titration of O and Vi antibodies by passive hemagglutination and Coombs' test in the blood of patients with typhoid fever].
Păscariu C; Bîlcea M; Feticu M; Lupaş A
Microbiol Parazitol Epidemiol (Bucur); 1969; 14(6):543-8. PubMed ID: 5378450
[No Abstract] [Full Text] [Related]
19. Editorial: Treatment of typhoid fever and typhoid carriers in Southeast Asia: --Viewpoint from Thailand.
Lexomboon U; Mansuwan P
Drugs; 1975; 9(4):243-5. PubMed ID: 1126308
[No Abstract] [Full Text] [Related]
20. Development of immune response during typhoid fever in man.
Sarma VN; Malaviya AN; Kumar R; Ghai OP; Bakhtary MM
Clin Exp Immunol; 1977 Apr; 28(1):35-9. PubMed ID: 862249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
